Table of Contents Table of Contents
Previous Page  161 / 464 Next Page
Information
Show Menu
Previous Page 161 / 464 Next Page
Page Background

INTERDISCIPLINARY RADIOBIOLOGY CLINICAL BRACHYTHERAPY PHYSICS RTT YOUNG

161

Programme and Exhibition Guide |

SCIENTIFIC PROGRAMME

TUESDAY 9 MAY 2017

Challenges remain in the radiobiological interpretation of moderate or extreme

hypofractionation in prostate cancer.

Chair: K. Haustermans (Belgium)

Co-chair: P. Agoston (Hungary)

11:00 > Moderate hypofractionation in prostate cancer: what have we learnt

from phase 3 trials

Speaker: D.P. Dearnaley (UK)

SP-0583

11:20 > Extreme hypofractionation – the future of prostate care or repeating

past mistakes?

Speaker: A. Loblaw (Canada)

SP-0584

11:40 > Hypofractionation in prostate cancer: a word of caution

Speaker: S. Bentzen (USA)

SP-0585

SYMPOSIUM

Is there any ground for boost brachytherapy in the time of high precision

IGRT/IMRT?

11:00 - 12:00 | SCHUBERT

Three experts in the field of external beam irradiation (EBI), brachytherapy, and

medical physics will review the role of brachytherapy boost in the era of high

precision external beam IGRT/IMRT. Prof Ozsahin will show current EBI boost

techniques in breast and GYN tumours including VMAT, Tomotherapy, CyberKnife,

SBRT, and protons. Current evidence and challenges of SBRT/IMRT boost using

IGRT will be presented. Prof Baltas will compare dose distributions of brachytherapy

versus simultaneous integrated EBI boost techniques with special emphasis on dose

gradient within the CTV. Dr Guinot will summarize the advantages of brachytherapy

boost over EBI techniques including better conformity and sparing of normal tissues,

steep dose gradient, and shorter overall treatment time. He will review long-term

clinical evidence supporting the use of brachytherapy boost in multiple sites (e.g.

prostate, GYN, breast, H&N, and anal canal).

Chair: C. Polgár (Hungary)

Co-chair: H. Stankusova (Czech Republic)

11:00 > The efficacy of IGRT/IMRT simultaneous integrated boost (SIB) in

gynaecology and breast

Speaker: E.M. Ozsahin (Switzerland)

SP-0586

11:20 > Dose gradients: the effect of high doses inside the CTV comparing

boost brachytherapy with SIB

Speaker: D. Baltas (Germany)

SP-0587